ArticleAlzheimer's research & therapy2023

A biomarker-validated time scale in years of disease progression has identified early- and late-onset subgroups in sporadic Alzheimer's disease.

Ove Almkvist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.